The Levofloxacin Hemihydrate prices in the U.S. pharmaceutical market likely to continue their upward trajectory until the end of April according to market forecasts. The surge in demand from the healthcare sector, coupled with restricted supply availability, remains the primary factor supporting this upward trend.
The driving force of the price rise is the steady demand of Levofloxacin Hemihydrate from end-user applications, particularly the healthcare sector. Levofloxacin Hemihydrate, a widely used antibiotic for treating respiratory and urinary tract infections, remains in strong demand across U.S. hospitals and drug manufacturing facilities. This steady consumption, coupled with constrained global supply, continues to put upward pressure on Levofloxacin Hemihydrate prices.
By March xxxx, Levofloxacin Hemihydrate prices had climbed to USD xx,xxx per metric ton CFR Los Angeles, driven by firm market fundamentals and intensified by evolving trade dynamics. On April x, xxxx, U.S. President Donald Trump introduced a reciprocal...
